JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

A cholesterol-dependent switch controls organ-specific metastasis in pancreatic cancer

  • 0Division of Tumor Metabolism and Microenvironment, German Cancer Research Center, Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Developmental Cell +

|

August 5, 2025

|

August 5, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Cancer cells adapt their metabolism to colonize different organs. Researchers found that PCSK9 (proprotein convertase subtilisin/kexin type 9) predicts organ colonization by regulating cholesterol metabolism.

Area Of Science

  • Oncology
  • Metabolic pathways
  • Cancer metastasis

Background

  • Cancer cells must adapt to distinct organ microenvironments for successful metastasis.
  • Metabolic reprogramming is crucial for cancer cell survival and colonization in foreign tissues.

Purpose Of The Study

  • To identify factors enabling cancer cells to adapt to diverse organ microenvironments.
  • To investigate the role of cholesterol metabolism in organ-specific metastasis.

Main Methods

  • Analysis of gene expression data.
  • In vivo metastasis models.
  • Metabolic profiling of cancer cells.

Main Results

  • PCSK9 (proprotein convertase subtilisin/kexin type 9) identified as a key regulator of organ colonization.
  • PCSK9 levels correlate with metastatic success in different organs.
  • Regulation of cholesterol metabolism by PCSK9 facilitates adaptation to specific microenvironments.

Conclusions

  • PCSK9 is a predictive biomarker for organ-specific metastatic colonization.
  • Targeting PCSK9-mediated cholesterol metabolism may offer therapeutic strategies for preventing metastasis.